NYSE · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · SMALL CAP
Concord Medical Services Holdings Ltd. CCM
17 fiscal years on record · CNY · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
¥460.5M
▲ 19.9% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-20.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
CNY 460.5M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 20 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
Dividend
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-56.8%
Net margin-20.2%
Return on assets-1.4%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+15.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−0.8%
+15.6%
−2.9%
+1.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years−4.0%
Change, 10 years—
The share count shrank 4% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
CNY 6.5B
total assets, end of FY2025
Total assetsCNY 6.5B
EquityCNY -2.1B
CashCNY 297.8M
Gross debtCNY 3.0B
Net debtCNY 2.7B
Current ratio0.48×
Net debt stands at -129% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · CNY
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue ¥B
0.5
0.4
0.5
0.5
0.5
0.2
0.2
0.2
0.3
0.5
0.6
0.6
0.6
0.5
0.5
0.4
0.3
Operating income ¥B
−0.3
−0.5
−0.5
−0.5
−0.5
−0.3
−0.4
−0.3
−0.2
−0.2
−0.0
0.2
0.2
0.2
−0.2
0.2
0.2
EBITDA ¥B
−0.2
−0.4
−0.4
−0.4
−0.4
−0.3
−0.4
−0.3
−0.1
−0.1
0.1
0.4
0.3
0.3
−0.1
0.3
0.2
Income tax ¥B
0.0
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
Net income ¥B
−0.1
−0.3
−0.3
−0.5
−0.3
−0.3
−0.3
−0.2
−0.3
−0.3
−0.1
0.1
0.1
0.1
−0.2
0.1
0.0
EPS, diluted ¥
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Dividend / sh ¥
·
·
·
·
·
·
·
·
·
·
0.00
0.00
0.00
0.00
0.00
·
·
Payout %
·
·
·
·
·
·
·
−0
−0
−109
−0
364
·
·
−26
·
35
ROE %
·
·
·
·
·
·
−195.2
−34.3
−27.1
−20.5
−4.9
6.4
4.1
6.6
−10.4
5.9
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
65 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed